Halozyme Therapeutics, Inc. (BMV:HALO)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,017.50
+59.50 (6.21%)
At close: May 16, 2025

Halozyme Therapeutics Ratios and Metrics

Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
133,981126,74882,540150,073116,003114,707
Upgrade
Market Cap Growth
88.11%53.56%-45.00%29.37%1.13%134.71%
Upgrade
Enterprise Value
149,280144,848100,236174,383117,299115,751
Upgrade
Last Close Price
1017.50680.00680.00679.74775.07-
Upgrade
PE Ratio
13.5113.7017.3438.0614.0544.66
Upgrade
PS Ratio
6.055.995.8911.6612.7621.54
Upgrade
PB Ratio
13.5916.7258.2645.3128.7338.17
Upgrade
P/TBV Ratio
----28.7338.17
Upgrade
P/FCF Ratio
13.2212.9913.0832.7018.99108.87
Upgrade
P/OCF Ratio
13.0112.7012.5732.0418.90103.95
Upgrade
EV/Sales Ratio
7.106.857.1513.5412.9121.74
Upgrade
EV/EBITDA Ratio
11.2911.0914.2226.6020.6339.89
Upgrade
EV/EBIT Ratio
12.8812.6117.4330.8920.7440.33
Upgrade
EV/FCF Ratio
14.7314.8415.8837.9919.20109.86
Upgrade
Debt / Equity Ratio
3.194.2218.279.074.472.66
Upgrade
Debt / EBITDA Ratio
2.252.423.594.543.152.71
Upgrade
Debt / FCF Ratio
3.103.284.106.552.957.59
Upgrade
Asset Turnover
0.540.540.460.450.530.47
Upgrade
Inventory Turnover
1.551.772.362.672.041.72
Upgrade
Quick Ratio
7.006.505.074.547.101.11
Upgrade
Current Ratio
8.397.806.645.657.911.32
Upgrade
Return on Equity (ROE)
147.06%198.42%222.07%110.23%231.44%106.33%
Upgrade
Return on Assets (ROA)
18.50%18.16%11.89%12.28%20.47%15.74%
Upgrade
Return on Capital (ROIC)
20.03%19.61%12.78%12.98%21.16%17.11%
Upgrade
Return on Capital Employed (ROCE)
29.20%28.70%21.00%16.90%27.90%91.00%
Upgrade
Earnings Yield
7.40%7.30%5.77%2.63%7.12%2.24%
Upgrade
FCF Yield
7.56%7.70%7.65%3.06%5.27%0.92%
Upgrade
Buyback Yield / Dilution
2.33%3.56%4.56%4.21%-3.77%1.99%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.